ADMA BIOLOGICS, INC. Underwriting Agreements
10 Contracts & Agreements
- Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of December 7, 2022 (Filed With SEC on December 7, 2022)
- Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of October 21, 2021 (Filed With SEC on October 21, 2021)
- Underwriting Agreement by and among the Company and the Underwriters dated as of February 6, 2020 (Filed With SEC on February 7, 2020)
- Underwriting Agreement by and among the Company and the Underwriters dated as of May 16, 2019 (Filed With SEC on May 17, 2019)
- Underwriting Agreement by and among the Company and the Underwriters dated as of June 8, 2018 (Filed With SEC on June 8, 2018)
- Underwriting Agreement, dated as of November 8, 2017, by and between the Company and Raymond James & Associates, Inc., as representatives of the several underwriters (Filed With SEC on November 9, 2017)
- Form of Underwriting Agreement (Filed With SEC on November 3, 2017)
- 1,892,308 Shares* ADMA Biologics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 28, 2016)
- [______________] Shares ADMA Biologics, Inc. Common Stock FORM OF UNDERWRITING AGREEMENT (Filed With SEC on April 22, 2013)
- [______________] Shares ADMA Biologics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 8, 2013)
